Daphne Weeks
Psychiatric/Mental Health · Gibsonton, FLNPI 1750981890
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 77.8% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $15,617, more than ten times the $620 reported in 2021. Among psychiatric/mental health clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $121.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$16K
- Alkermes, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$642
- Otsuka America Pharmaceutical, Inc.$569
- AbbVie$392
- E.r. Squibb & Sons, L.L.C.$262
- plus $967 from 6 others
What the payments were for
- Speaking & faculty fees$11,22055%
- Travel & lodging$2,58113%
- Food & beverage$6,42331%
- Education$2111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 47 | $15,906 |
| Alkermes, Inc. | 39 | $1,697 |
| Teva Pharmaceuticals USA, Inc. | 27 | $642 |
| Otsuka America Pharmaceutical, Inc. | 15 | $569 |
| AbbVie | 5 | $392 |
| E.r. Squibb & Sons, L.L.C. | 5 | $262 |
| Neurocrine Biosciences, Inc. | 9 | $256 |
| Janssen Scientific Affairs, LLC | 5 | $249 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $232 |
| Indivior Inc. | 8 | $165 |
| Sunovion Pharmaceuticals Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$15,105
- INVEGA TRINZA$14,455
- ARISTADA$1,846
- LYBALVI$1,562
- VRAYLAR$344
- ARISTADA INITIO$344
- COBENFY$247
- SPRAVATO$139
- CAPLYTA$125
- ABILIFY MAINTENA$122
- ABILIFY ASIMTUFII$122
- UZEDY$114
How this compares
$20,435 in reported general payments places this provider in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 143 | $508,064 |
| Austedo XrDeutetrabenazine | 31 | $356,414 |
| Invega TrinzaPaliperidone Palmitate | 31 | $330,748 |
| Abilify MaintenaAripiprazole | 25 | $77,294 |
| Aripiprazole | 104 | $18,498 |
| LatudaLurasidone Hcl | 14 | $16,236 |
| Paliperidone ErPaliperidone | 87 | $15,848 |
| Clozapine | 86 | $10,316 |
| TrintellixVortioxetine Hydrobromide | 21 | $10,024 |
| Fluphenazine Hcl | 13 | $6,001 |
| Quetiapine Fumarate | 237 | $5,910 |
| Lurasidone Hcl | 30 | $5,538 |
| Mirtazapine | 166 | $4,171 |
| Haloperidol Decanoate | 56 | $4,078 |
| Olanzapine | 183 | $4,044 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $15,906 | $838,813174 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $642 | $356,41431 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $569 | $77,29425 claims |
| Sunovion Pharmaceuticals Inc.Latuda | $38 | $16,23614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,096 psychiatric/mental health providers in Florida.
Other psychiatric/mental health in Gibsonton
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
- Angela DavenportAlachua$83K
- Natalie MoodyWinter Haven$75K
- Kelli BridgmanNew Smyrna Beach$66K
- Carolann BrooksCelebration$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.